title: Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanoma.
authors.affiliation: Department of Dermatology, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, U.K.
authors.forename: R
authors.initials: R
authors.lastname: Sinha
authors.forename: K
authors.initials: K
authors.lastname: Lecamwasam
authors.forename: K
authors.initials: K
authors.lastname: Purshouse
authors.forename: J
authors.initials: J
authors.lastname: Reed
authors.forename: M R
authors.initials: MR
authors.lastname: Middleton
authors.forename: L
authors.initials: L
authors.lastname: Fearfield
mesh_terms: D000368:Aged; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib